Effect of finasteride on human testicular steroidogenesis

Journal of Andrology

Volumn 17, Issue 5, 1996, Pages 516-521

  Castro Magana, Mariano ^a,b   Angulo, Moris ^a,b   Fuentes, Billy ^c   Canas, Atilio ^a,b   Sarrantonio, Mary ^a,b   Arguello, Raul ^a,b   Vitollo, Pam ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Hospital Nacional de Ninos Benjamin Bloom   (El Salvador)

Author keywords

17 ketosteroid reductase; 5 reductase; Alopecia; baldness; prostate

Indexed keywords

17 OXOSTEROID; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE;

ADULT; ALOPECIA; ARTICLE; CHROMOSOME 2; CLINICAL ARTICLE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME LOCALIZATION; GONADOTROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HUMAN; MALE; PRIORITY JOURNAL; STEROIDOGENESIS; TESTIS FUNCTION;

ADULT; ALOPECIA; CHOLESTENONE 5 ALPHA-REDUCTASE; CHORIONIC GONADOTROPIN; ENZYME INHIBITORS; FINASTERIDE; GONADAL STEROID HORMONES; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; MALE; OXIDOREDUCTASES; PROSTATE; STEROIDS; TESTIS;

EID: 0029806459     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Anderson S, Berman DM, Jenkin EP Russel DW. Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 1991;354: 159-161.
2. Anderson S, Bishop RW, Russell DW. Expression, cloning and regulation of steroid 5 alpha-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 1989;264:16249-16255.
3. Castro-Magana M, Angulo M, Canas A, Sharp A, Fuentes B. Hypothalamic pituitary gonadal axis in boys with primary hypothyroidism and macroorchidisim. J Pediatr 1988;112:397-402.
4. Castro-Magana M, Angulo M, Uy J. Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. N Engl J Med 1993;328:1297-1301.
5. Dallob AL, Sadick, NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK. The effect of finasteride, a 5α-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 1994;79:703-706.
6. Diani AR, Mulholland MJ, Shull KL, Kubicek MF, Johnson GA, Schostarez HJ, Brunden MN, Buhl AE. Hair growth effects of oral administration of finasteride, a steroid 5α-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. J Clin Endocrinol Metab 1992;74:345-350.
7. Fruzzetti F, deLorenzo D, Parrini D, Ricci C. Effects of finasteride, a 5α-reductase inhibitor, on circulating androgens and gonadotropins secretion in hirsute women. J Clin Endocrinol Metab 1994;79:831-835.
8. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley JI, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Pappas F, Taylor A, Binkowitz B, Ng J. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992;327:1185-1191.
9. Gormley GJ, Stoner E, Rittmaster RS, Gregg H, Thompson DL, Lasseter KC, Vlasses PH, Stein EA. Effects of finasteride (MK-906), a 5α-reductase inhibitor, on circulating androgens in male volunteers. J Clin Endocrinol Metab 1990;70:1136-1141.
10. Hamilton JB. Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anat 1942;71:451-480.
11. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci 1951;53:708-711.
12. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974;186:1213-1215.
13. Inkster S, Yue W, Brodie A. Human testicular aromatase: immunocytochemical and biochemical studies. J Clin Endocrinol Metab 1995;80: 1941-1947.
14. Itami S, Kurata S, Sonoda J, Takayasu S. Characterization of 5α-reductase in cultured human dermal papilla cells from beard and occipital scalp hair. J Invest Dermatol 1991;96:57-60.
15. Jenkins EP, Anderson S, Imperato-McGinley J, Wilson JD, Russell DW. Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J Clin Invest 1992;89:293-300.
16. Jenkins EP, Hsieh CL, Milatovich A, Normington K, Berman DM, Francke U, Russell DW. Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homologue. Genomics 1991;11:1102-1112.
17. 450 and 5α-reductase enzyme activities and mRNA levels during the estrous cycle in the rat. J Steroid Biochem Mol Biol 1992;42:439-447.
18. Lookingbill DP, Egan N, Santen RJ, Demers LM. Correlation of serum 3-androstenediol glucuronide with acne and chest hair density in men. J Clin Endocrinol Metab 1988;67:986-991.
19. Marynick SP, Loriaux DL, Sherins RJ, Pita JC Jr, Lopsett MB. Evidence that testosterone can suppress pituitary gonadotropin secretion independently of peripheral aromatization. J Clin Endocrinol Metab 1979; 49:396-398.
20. McNatty KP, Makris A, Reinhold VN, DeGracia C, Osathanondh R, Ryan KJ. Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and armatase activity. Steroids 1979;34:429-443.
21. Mikhail G, Wu CH, Ferrin M, Vande Wiele RL. Radioimmunoassay of plasma estrone and estradiol. Steroids 1970;15:333-352.
22. Moghetti P, Castello R, Magnani CM, Tosi F, Wegri C, Armanini D, Bellotti G, Muggeo M. Clinical and hormonal effects of the 5α-reductase inhibitor finasteride in idiopathic hirsutism. J Clin Endocrinol Metab 1994;79:1115-1121.
23. Moghissi E, Ablan F, Horton R. Origin of plasma androstanediol glucuronide in men. J Clin Endocrinol Metab 1984;59:417-421.
24. Moore RJ, Wilson JD. Steroid 5α-reductase in cultured human fibroblasts: biochemical and genetic evidence for two distinct enzyme activities. J Biol Chem 1976;251:5895-5900.
25. Payne AH, Chase DJ, O'Shaughnessy PJ. Regulation of steroidogenesis in Leydig cell. In: Conn PM, ed. Cellular Regulation of Secretion and Release. New York: Academic Press; 1982:355-408.
26. Rhodes L, Harper J, Uno H, Gaito G, Audette-Arruda J, Kurata S, Berman C, Primka R, Pikounis B. The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaco aractoides). J Clin Endocrinol Metab 1994;79:991-996.
27. Rittmaster RS, Antonian L, New M, Stoner E. Effect of finasteride on adrenal steroidogenesis in men. J Androl 1994;15:298-301.
28. Rittmaster RS, Lemay A, Zwicker H, Capizzi TP, Winch S, Moore E, Goemley GJ. Effect of finasteride. a 5α-reductase inhibitor, on serum gonadotropins in normal men. J Clin Endocrinol Metab 1992;75:484-488.
29. Rittmaster RS, Thompson DL, Listwak S, Loriaux DC. Androstanediol glucuronide isomers in normal men and women and in men infused with labeled dihydrotestosterone. J Clin Endocrinol Metab 1988;66: 212-216.
30. Stoner E. The clinical development of a 5α-reductase inhibitor, finasteride. J Steroid Biochem Mol Biol 1990;37:375-378.
31. Vihko P, Kurkela R, Ramberg J, Pelkonen I, Vihko R. Time-resolved immunofluorometric assay of human prostate-specific antigen. Clin Chem 1990;36:92-95.